Objectives-To review the experience of renal replacement treatment in diabetic patients treated in Newcastle upon Tyne and the Northern region from 1964 to 1988, and to compare the morbidity and mortality of diabetic patients treated with dialysis or transplantation with those of matched controls of non-diabetic patients.
Introduction
End stage renal failure is an important cause of death in diabetic patients, especially in those in whom diabetes develops at a young age. In the United Kingdom in 1979 it was the cause of death in 15% of those aged under 50 and a quarter of those in whom it was diagnosed before the age of 31.' About a fifth of insulin dependent diabetic patients will develop end stage renal failure within 25 years after diagnosis,2 although this incidence may be falling.
When renal replacement treatment first became available diabetic patients were often not considered for treatment because of limited facilities. In the past 10 years, however, increasing numbers of diabetic patients have been accepted for treatment and in some countries diabetic nephropathy is now the most common diagnosis among patients newly accepted for dialysis.34
Many reports have described experiences with renal replacement treatment in diabetic patients,3 -several of which compared findings with a control group," 2 13 but to our knowledge in none has a comparison been made with a matched control group of non-diabetic patients treated in the same unit. In this study we reviewed the experience ofrenal replacement treatment in diabetic patients treated in Newcastle upon Tyne and the Northern region. We also compared the morbidity and mortality of a group of diabetic patients treated with dialysis or transplantation, or both, with those of a matched control group of non-diabetic patients.
Methods

ACCEPTANCE RATES IN THE NORTHERN REGION
In the Northern region renal replacement treatment is available in renal units in Newcastle upon Tyne, Sunderland, and Middlesbrough, which opened in 1964, 1968, and 1969 respectively. Newcastle upon Tyne is also the regional centre for kidney and pancreatic transplantation. The acceptance rate by year per million population was calculated from the total number of diabetic and non-diabetic patients accepted for renal replacement treatment (3) respectively. The mean duration of treatment (with diet or hypoglycaemic drugs, or both) in the patients with non-insulin dependent diabetes was 11 (2) years. Only one patient with non-insulin dependent diabetes was treated with oral hypoglycaemic drugs for one year. Renal biopsy was performed in 12 (18%) patients, in whom some doubt existed about pathogenesis of the disease; diabetic nephropathy was confirmed in nine and glomerulonephritis was found in the three others. Fifty three (82%) patients were treated initially with peritoneal dialysis, 10 (15%) with haemodialysis and two (3%) received a transplant before the onset of dialysis.
Renal and pancreatic transplantation-Fifty two patients (80%) were accepted for renal transplantation and thereafter 33 (51%) received a transplant. The mean age of the patients who received a transplant was significantly lower than that of those did not (41 (2) v 48 (2), p<0 05). Of these 33 patients, 22 had been previously treated with peritoneal dialysis, nine with haemodialysis, and two had received transplants before dialysis. Six patients had a combined pancreatic and renal transplant. The survival of the pancreatic graft in these patients was 54 months (censored observation), 11 months (censored observation), and 2, 0, 0, and 0 months respectively. Ten of the patients had a biopsy of the transplanted kidney for "late" progressive deterioration in renal function, and in only one was severe diabetic nephropathy found; the others showed various degrees ofchronic rejection. The Continuous ambulatory peritoneal dialysis-Sixteen patients in each group were treated initially by continuous ambulatory peritoneal dialysis. Survival of the diabetic patients was lower than that of the controls, although the difference was not significantly different ( fig 2) . Survival of the technique was similar in the two groups (fig 2) , and there was no difference in either the time to the first episode of peritonitis (diabetic patients 28 (9) v controls 28 (11) weeks) or the survival of the first peritoneal catheter (fig 2) . Although survival ofthe catheter to the first episode of peritonitis was similar in the two groups, the overall rates of bacterial and fungal peritonitis were significantly higher in the diabetic patients (bacterial peritonitis, one episode/6 1 patient months v one episode/12-4 patient months, p<OOOl; fungal peritonitis, one episode/74 patient months v one episode/564 patient months, p<O 05). , p<0001) (fig 5) . Cumulative survival of the transplanted kidney (fig 6) was not significantly different in the two groups (one year survival in diabetic patients 73% v controls 70%; five year survival in diabetic patients 64% v controls 46%).
Cause of death-Cerebrovascular accidents were a significant cause of death in only the diabetic patients (table II) In the United States about half of diabetic patients having haemodialysis have non-insulin dependent diabetes'9 whereas most of our patients had insulin dependent diabetes, and this is reflected by the younger age of our patients (44 v 60).
Renal biopsy is performed in our diabetic patients only when the primary renal diagnosis is uncertain, when patients present without proliferative retinopathy, with diabetes of a short duration, and with an 10 s 14 16 unexplainable, unexpected deterioration in renal 0 1c2t 14 16 function. Twelve patients had a biopsy and three (25%) were found to have non-diabetic renal disease. This receiving renal proportion is similar to that in selected populations of diabetics with renal impairment.20-22 In only one of 10 transplanted kidneys was recurrent diabetic glomerulosclerosis found on biopsy. This low incidence ----Diabetic patients may be related to the fairly short period of observation.
-Controls
Goetz et al reported a higher incidence of recurrence in diabetic patients 10 years after transplantation.6 Over 80% of our diabetic patients were treated initially with peritoneal dialysis (80% with continuous ambulatory peritoneal dialysis). This rate represents the popularity of peritoneal dialysis in Newcastle upon Tyne (60% of dialysis patients in 1988 received continuous ambulatory peritoneal dialysis) and is higher than that for the rest of the United Kingdom and Europe (21% and 7% respectively of all dialysis patients, 43% Twenty three per cent of the deaths in our diabetic patients were the result of cerebrovascular accidents whereas no deaths from this cause occurred in the control group. Cerebrovascular accidents are both more common and more often fatal in diabetic patients with and without diabetic nephropathy.1"21
In summary, our experience of renal replacement treatment in diabetic patients is similar to that of others. Diabetes strongly influences both morbidity and mortality; however, the six year survival of diabetic patients receiving a kidney transplant is over 70%.
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